Disclosure Of First-Time Adoption [Text Block]

RaySearch Laboratories - Filing #677636

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	735 232 SEK	—	721 982 SEK	—	—	17 141 SEK	5 866 SEK	735 232 SEK	1 975 SEK	657 156 SEK	—	—	640 410 SEK	17 141 SEK	2 370 SEK	657 156 SEK	1 975 SEK	—	—	616 632 SEK	1 975 SEK	628 312 SEK	17 141 SEK	7 436 SEK
Comprehensive income	78 076 SEK	—	78 076 SEK	—	81 572 SEK	3 496 SEK	—	—	—	—	—	28 844 SEK	23 778 SEK	—	—	—	—	—	28 844 SEK	5 066 SEK	—	—	—	—	—
Profit (loss)	81 572 SEK	—	81 572 SEK	—	81 572 SEK	—	—	—	—	—	—	23 778 SEK	23 778 SEK	—	—	—	—	—	23 778 SEK	—	—	—	—	—	—